Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Albuminuria | Research article

Serum 25-Hydroxyvitamin D were associated with higher risk of both albuminuria and impaired GFR incidence: a cohort study based on CLHLS study

Authors: Miao Liu, Jianhua Wang, Yao He

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

This study aimed to examine the relationship between 25-hyfromxyvitamin D (25OHD) and chronic kidney disease (CKD) incidence.

Methods

All the elderly who had participated both in the 2011–2012 survey and 2014 survey in the Chinese Longitudinal Healthy Longevity Survey (CLHLS), and have biomarker data were included in the analysis. We studied those without CKD with complete data at 2011–2012 waves. Serum 25-Hydroxyvitamin D was assessed at baseline. Cox proportional risk model was used to evaluate associations between serum 25-Hydroxyvitamin D and CKD (including both albuminuria and impaired eGFR) incidence after adjusted for potential confounding..

Results

During the follow-up years, 255 incident cases of CKD were diagnosed. Those who developed CKD had relatively lower serum 25(OH)D (mean 37.63 vs.51.36 nmol/L, p < 0.001) compared with those who remained free of CKD. Each 1 nmol/L increase in 25(OH)D was associated with 3.4% reduced risk of CKD (HR = 0.966, 95%CI: 0.959–0.973) after adjusted for related covariates. The HRs of each 1 nmol/L increase in 25(OH)D for albuminuria and impaired eGFR were 0.952(95%CI: 0.941–0.963) and 0.975(95%CI: 0.966–0.983) respectively. When use the classifications (sufficiency, insufficiency, deficiency) or quintiles of baseline 25(OH)D levels in the Cox model, the corresponding HRs showed an increasing trend along with the decrease of baseline 25(OH)D levels (p for trend < 0.001).

Conclusions

Higher 25(OH)D levels were inversely and independently associated with CKD incidence among Chinese elderly. The trend for the observed linear relationship b was most pronounced among the lowest quintile.
Appendix
Available only for authorised users
Literature
1.
go back to reference Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab. 2013;95(2):471.CrossRef Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab. 2013;95(2):471.CrossRef
2.
go back to reference Ekmekcioglu C, Haluza D, Kundi M. 25-Hydroxyvitamin D status and risk for colorectal Cancer and type 2 diabetes mellitus: a systematic review and meta-analysis of epidemiological studies. Int J Environ Res Public Health. 2017;14(2):127.CrossRef Ekmekcioglu C, Haluza D, Kundi M. 25-Hydroxyvitamin D status and risk for colorectal Cancer and type 2 diabetes mellitus: a systematic review and meta-analysis of epidemiological studies. Int J Environ Res Public Health. 2017;14(2):127.CrossRef
3.
go back to reference Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005;14(8):1991.CrossRef Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005;14(8):1991.CrossRef
4.
go back to reference Damasiewicz MJ, Magliano DJ, Daly RM, Gagnon C, Zhong XL, Ebeling PR, et al. 25-hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian diabetes, obesity and lifestyle) study. BMC Nephrol. 2012;13(1):55.CrossRef Damasiewicz MJ, Magliano DJ, Daly RM, Gagnon C, Zhong XL, Ebeling PR, et al. 25-hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian diabetes, obesity and lifestyle) study. BMC Nephrol. 2012;13(1):55.CrossRef
5.
go back to reference Elfakhri N, Mcdevitt H, Shaikh MG, Halsey C, Ahmed SF. Vitamin D and its effects on glucose homeostasis, cardiovascular function and immune function. Horm Res Paediatr. 2014;81(6):363–78.CrossRef Elfakhri N, Mcdevitt H, Shaikh MG, Halsey C, Ahmed SF. Vitamin D and its effects on glucose homeostasis, cardiovascular function and immune function. Horm Res Paediatr. 2014;81(6):363–78.CrossRef
6.
go back to reference Artaza JN, Sirad F, Ferrini MG, Norris KC. 1,25(OH)2 vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells. J Steroid Biochem Mol Biol. 2010;119(1–2):73.CrossRef Artaza JN, Sirad F, Ferrini MG, Norris KC. 1,25(OH)2 vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells. J Steroid Biochem Mol Biol. 2010;119(1–2):73.CrossRef
7.
go back to reference Yano Y, Fujimoto S, Asahi K, Watanabe T. Prevalence of chronic kidney disease in China. Lancet. 2012;380(9838):815–22.CrossRef Yano Y, Fujimoto S, Asahi K, Watanabe T. Prevalence of chronic kidney disease in China. Lancet. 2012;380(9838):815–22.CrossRef
8.
go back to reference Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and nutrition examination survey. Am J Kidney Dis. 2003;41(1):1–12.CrossRef Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and nutrition examination survey. Am J Kidney Dis. 2003;41(1):1–12.CrossRef
9.
go back to reference Wang S, Chen R, Liu Q, Shu Z, Zhan S, Li L. Prevalence, awareness and treatment of chronic kidney disease among middle-aged and elderly: the China health and retirement longitudinal study. Nephrology. 2015;20(7):474–84.CrossRef Wang S, Chen R, Liu Q, Shu Z, Zhan S, Li L. Prevalence, awareness and treatment of chronic kidney disease among middle-aged and elderly: the China health and retirement longitudinal study. Nephrology. 2015;20(7):474–84.CrossRef
10.
go back to reference de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS. 25-Hydroxyvitamin D levels and albuminuria in the third National Health and nutrition examination survey (NHANES III). Am J Kidney Dis. 2007;50(1):69–77.CrossRef de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS. 25-Hydroxyvitamin D levels and albuminuria in the third National Health and nutrition examination survey (NHANES III). Am J Kidney Dis. 2007;50(1):69–77.CrossRef
11.
go back to reference González EA, Sachdeva A, Oliver DA, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease. Am J Nephrol. 2004;24(5):503–10.CrossRef González EA, Sachdeva A, Oliver DA, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease. Am J Nephrol. 2004;24(5):503–10.CrossRef
12.
go back to reference Mckibben RA, Zhao D, Lutsey PL, Schneider AL, Guallar E, Mosley TH, Michos ED. Factors associated with change in 25-hydroxyvitamin D levels over longitudinal followup in the ARIC study. J Clin Endocrinol Metab. 2016;101(1):33–43.CrossRef Mckibben RA, Zhao D, Lutsey PL, Schneider AL, Guallar E, Mosley TH, Michos ED. Factors associated with change in 25-hydroxyvitamin D levels over longitudinal followup in the ARIC study. J Clin Endocrinol Metab. 2016;101(1):33–43.CrossRef
13.
go back to reference Boer IHD, Katz R, Chonchol M, Ix JH, Sarnak MJ, Shlipak MG, et al. Serum 25-Hydroxyvitamin D and change in estimated glomerular filtration rate. Clinical Journal of the American Society of Nephrology Cjasn. 2141;6(9):2011. Boer IHD, Katz R, Chonchol M, Ix JH, Sarnak MJ, Shlipak MG, et al. Serum 25-Hydroxyvitamin D and change in estimated glomerular filtration rate. Clinical Journal of the American Society of Nephrology Cjasn. 2141;6(9):2011.
14.
go back to reference Zeng Y. Chinese longitudinal healthy longevity survey(1998-2012) and related policy research review. Scientific Research on Aging. 2013. Zeng Y. Chinese longitudinal healthy longevity survey(1998-2012) and related policy research review. Scientific Research on Aging. 2013.
15.
go back to reference Holick MF, Binkley NC, Bischoffferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911.CrossRef Holick MF, Binkley NC, Bischoffferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911.CrossRef
16.
go back to reference Liao Y, Liao W, Liu J, Xu G, Zeng R. Assessment of the CKD-EPI equation to estimate glomerular filtration rate in adults from a Chinese CKD population. J Int Med Res. 2011;39(6):2273.CrossRef Liao Y, Liao W, Liu J, Xu G, Zeng R. Assessment of the CKD-EPI equation to estimate glomerular filtration rate in adults from a Chinese CKD population. J Int Med Res. 2011;39(6):2273.CrossRef
17.
go back to reference Isakova T, Gutiérrez OM, Patel NM, Andress DL, Wolf M, Levin A. Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr. 2011;21(4):295–302.CrossRef Isakova T, Gutiérrez OM, Patel NM, Andress DL, Wolf M, Levin A. Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr. 2011;21(4):295–302.CrossRef
18.
go back to reference Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009;75(1):88–95.CrossRef Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009;75(1):88–95.CrossRef
19.
go back to reference Reynolds BS, Lefebvre HP. Feline CKD: Pathophysiology and risk factors--what do we know? Journal of Feline Medicine & Surgery 2013;15 Suppl 1(S1):3. Reynolds BS, Lefebvre HP. Feline CKD: Pathophysiology and risk factors--what do we know? Journal of Feline Medicine & Surgery 2013;15 Suppl 1(S1):3.
20.
go back to reference Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006;69(1):33–43.CrossRef Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006;69(1):33–43.CrossRef
21.
go back to reference Szeto CC, Li KT. The use of vitamin D analogues in chronic kidney diseases: possible mechanisms beyond bone and mineral metabolism. Ndt Plus. 2009;2(3):205–12.PubMedPubMedCentral Szeto CC, Li KT. The use of vitamin D analogues in chronic kidney diseases: possible mechanisms beyond bone and mineral metabolism. Ndt Plus. 2009;2(3):205–12.PubMedPubMedCentral
22.
go back to reference Brown JM, Secinaro K, Williams JS, Vaidya A. Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study. BMC Endocr Disord. 2013;13(1):33.CrossRef Brown JM, Secinaro K, Williams JS, Vaidya A. Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study. BMC Endocr Disord. 2013;13(1):33.CrossRef
Metadata
Title
Serum 25-Hydroxyvitamin D were associated with higher risk of both albuminuria and impaired GFR incidence: a cohort study based on CLHLS study
Authors
Miao Liu
Jianhua Wang
Yao He
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1202-8

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue